U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Acquired amyloid peripheral neuropathy

MedGen UID:
1842821
•Concept ID:
C5680847
•
Disease or Syndrome
Orphanet: ORPHA209013

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVAcquired amyloid peripheral neuropathy

Professional guidelines

PubMed

Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.
Rigopoulos AG, Ali M, Abate E, Torky AR, Matiakis M, Mammadov M, Melnyk H, Vogt A, de Vecchis R, Bigalke B, Wohlgemuth W, Mavrogeni S, Noutsias M
Heart Fail Rev 2019 Jul;24(4):521-533. doi: 10.1007/s10741-019-09776-3. PMID: 30790171
Current and future treatment of amyloid neuropathies.
Adams D, Cauquil C, Theaudin M, Rousseau A, Algalarrondo V, Slama MS
Expert Rev Neurother 2014 Dec;14(12):1437-51. Epub 2014 Nov 21 doi: 10.1586/14737175.2014.983905. PMID: 25416603
Cardiac amyloidosis: updates in diagnosis and management.
Mohty D, Damy T, Cosnay P, Echahidi N, Casset-Senon D, Virot P, Jaccard A
Arch Cardiovasc Dis 2013 Oct;106(10):528-40. Epub 2013 Sep 23 doi: 10.1016/j.acvd.2013.06.051. PMID: 24070600

Recent clinical studies

Therapy

Resveratrol Derivatives Inhibit Transthyretin Fibrillization: Structural Insights into the Interactions between Resveratrol Derivatives and Transthyretin.
Yokoyama T, Kusaka K, Mizuguchi M, Nabeshima Y, Fujiwara S
J Med Chem 2023 Nov 23;66(22):15511-15523. Epub 2023 Nov 1 doi: 10.1021/acs.jmedchem.3c01698. PMID: 37910439
Therapy of ATTR Cardiac Amyloidosis: Current Indications.
Di Lisi D, Di Stefano V, Brighina F, Galassi AR, Novo G
Curr Probl Cardiol 2023 Feb;48(2):101487. Epub 2022 Nov 4 doi: 10.1016/j.cpcardiol.2022.101487. PMID: 36336119
Autonomic neuropathies.
Kaur D, Tiwana H, Stino A, Sandroni P
Muscle Nerve 2021 Jan;63(1):10-21. Epub 2020 Sep 14 doi: 10.1002/mus.27048. PMID: 32926436
Diagnosis of amyloid neuropathy.
Kapoor M, Rossor AM, Jaunmuktane Z, Lunn MPT, Reilly MM
Pract Neurol 2019 Jun;19(3):250-258. Epub 2018 Dec 30 doi: 10.1136/practneurol-2018-002098. PMID: 30598431
Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
Sekijima Y
J Neurol Neurosurg Psychiatry 2015 Sep;86(9):1036-43. Epub 2015 Jan 20 doi: 10.1136/jnnp-2014-308724. PMID: 25604431

Prognosis

Acquired and inherited amyloidosis: Knowledge driving patients' care.
Obici L, Adams D
J Peripher Nerv Syst 2020 Jun;25(2):85-101. doi: 10.1111/jns.12381. PMID: 32378274
Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis.
Lane T, Fontana M, Martinez-Naharro A, Quarta CC, Whelan CJ, Petrie A, Rowczenio DM, Gilbertson JA, Hutt DF, Rezk T, Strehina SG, Caringal-Galima J, Manwani R, Sharpley FA, Wechalekar AD, Lachmann HJ, Mahmood S, Sachchithanantham S, Drage EPS, Jenner HD, McDonald R, Bertolli O, Calleja A, Hawkins PN, Gillmore JD
Circulation 2019 Jul 2;140(1):16-26. Epub 2019 May 21 doi: 10.1161/CIRCULATIONAHA.118.038169. PMID: 31109193
Unfolding Cardiac Amyloidosis -From Pathophysiology to Cure.
Ablasser K, Verheyen N, Glantschnig T, Agnetti G, Rainer PP
Curr Med Chem 2019;26(16):2865-2878. doi: 10.2174/0929867325666180104153338. PMID: 29303069
Amyloid neuropathies.
Shin SC, Robinson-Papp J
Mt Sinai J Med 2012 Nov-Dec;79(6):733-48. doi: 10.1002/msj.21352. PMID: 23239211Free PMC Article
Hereditary and acquired amyloid neuropathies.
Adams D
J Neurol 2001 Aug;248(8):647-57. doi: 10.1007/s004150170109. PMID: 11569892

Clinical prediction guides

Resveratrol Derivatives Inhibit Transthyretin Fibrillization: Structural Insights into the Interactions between Resveratrol Derivatives and Transthyretin.
Yokoyama T, Kusaka K, Mizuguchi M, Nabeshima Y, Fujiwara S
J Med Chem 2023 Nov 23;66(22):15511-15523. Epub 2023 Nov 1 doi: 10.1021/acs.jmedchem.3c01698. PMID: 37910439
Acquired and inherited amyloidosis: Knowledge driving patients' care.
Obici L, Adams D
J Peripher Nerv Syst 2020 Jun;25(2):85-101. doi: 10.1111/jns.12381. PMID: 32378274
Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series.
Waddington-Cruz M, Schmidt H, Botteman MF, Carter JA, Stewart M, Hopps M, Fallet S, Amass L
Orphanet J Rare Dis 2019 Feb 8;14(1):34. doi: 10.1186/s13023-019-1000-1. PMID: 30736835Free PMC Article
Unfolding Cardiac Amyloidosis -From Pathophysiology to Cure.
Ablasser K, Verheyen N, Glantschnig T, Agnetti G, Rainer PP
Curr Med Chem 2019;26(16):2865-2878. doi: 10.2174/0929867325666180104153338. PMID: 29303069
Current and future treatment of amyloid neuropathies.
Adams D, Cauquil C, Theaudin M, Rousseau A, Algalarrondo V, Slama MS
Expert Rev Neurother 2014 Dec;14(12):1437-51. Epub 2014 Nov 21 doi: 10.1586/14737175.2014.983905. PMID: 25416603

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Reviews

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...